In the case of clinical trials, for me the need is more of them in general and more of them on severe patients. But if we combine the two needs into one demand it doesn't necessarily gain anything.
The demand should be sperated as the patient cohort maybe of difďerenr sibtype. Keen observasation I think a revieion is in order